AquaBounty Technologies, Inc
AquaBounty Technologies Inc. is a U.S.-based aquaculture company that was built around producing genetically engineered Atlantic salmon in land-based recirculating aquaculture systems (RAS). In recent years, the company has sharply scaled back operations after pausing construction of its Ohio farm, selling its Indiana grow-out farm, disposing of equipment tied to the Ohio project, and selling its Canadian subsidiary and intellectual property in 2025. What remains is primarily the Ohio Farm Site and related assets, while management is seeking new investment, a partnership, or another strategic path to realize value from that project. The business is now in a restructuring and asset-monetization phase rather than a normal operating growth phase.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueProduction of genetically engineered Atlantic salmon intended for commercial fish sales.
Construction and operation of land-based recirculating aquaculture facilities for salmon rearing.
Broodstock farms and egg-production capabilities used to support salmon lifecycle management.
Patents, trademarks, and related IP tied to the GE Atlantic salmon platform.
Customers
Historically, AquaBounty sold Atlantic salmon into the food supply chain, with demand coming from buyers that value a controlled, land-based production model and differentiated fish supply. Its end customers would typically include seafood distributors, wholesalers, foodservice operators, and retail channels that purchase salmon for resale or menu use. The company’s business model also depended on strategic capital providers and partners because large RAS farms require substantial upfront funding before meaningful commercial output. After the 2024-2025 asset sales, the company’s immediate focus is less on serving recurring fish customers and more on finding investors, partners, or acquirers for the Ohio Farm Site.
Buy salmon in bulk for onward sale into retail and foodservice channels, valuing consistent supply and product differentiation.
Purchase salmon for packaged seafood offerings, typically seeking reliable volume and a sustainability or traceability story.
Buy salmon for menu use, with demand tied to quality, availability, and price competitiveness.
Provide funding, development support, or operating partnerships to complete the Ohio Farm Project and monetize the asset base.
Strategy
AquaBounty’s strategy has shifted from building a scaled salmon production platform to preserving value from a much smaller asset base. Management has paused the Ohio Farm construction, sold non-core and discontinued assets, and is now seeking the optimal path forward for the remaining project through new investment, a partnership, or another strategic transaction. The company is also focused on reducing operating costs and maintaining only a small corporate team while it evaluates alternatives. In practical terms, the strategy is about liquidity preservation, asset monetization, and finding a financing structure that can complete or unlock the Ohio Farm Site.
The remaining project cannot be completed without additional capital, and the company’s future depends on unlocking value from this asset.
With operations largely wound down, lower fixed costs are necessary to preserve liquidity and extend runway.
Asset sales and strategic transactions are the main path to recover value after the operating model was scaled back.
Geography
AquaBounty is headquartered in the United States and its remaining core asset is the Ohio Farm Site in Pioneer, Ohio. Historically, the company also operated in Indiana and Canada, including broodstock farms in Prince Edward Island, but those assets were sold in 2024 and 2025 and are now discontinued operations. The company’s operational footprint has therefore contracted materially, leaving a much narrower U.S.-centric presence. Geography now matters mainly because the Ohio project is the last major asset and its completion depends on local financing, permitting, and construction conditions.
Risks
The company faces severe going-concern and liquidity risk because it has a history of losses, very limited cash, and needs new funding to continue. Execution risk is high because the Ohio Farm Project was paused after cost inflation materially increased the completion estimate and undermined the original financing plan. There is also listing risk, as failure to meet Nasdaq requirements could reduce liquidity and access to capital. More broadly, AquaBounty is exposed to construction, financing, regulatory, and aquaculture industry risks, including cost inflation, project delays, and the challenge of commercializing a novel production model at scale.
- Going-concern and liquidity shortfallImpact: CriticalLikelihood: High
The company states it requires new funding to provide working capital and complete the Ohio Farm Project, and it has very limited cash relative to its obligations.
Exposure: Corporate liquidity and ability to continue operations
- Nasdaq listing compliance failureImpact: HighLikelihood: High
A delisting would likely reduce trading liquidity, analyst coverage, and the company’s ability to raise capital.
Exposure: Capital markets access and shareholder liquidity
- Construction cost escalation and project delayImpact: HighLikelihood: High
The Ohio Farm was paused after completion costs rose substantially due to inflation and other factors, undermining the original funding plan.
Exposure: Ohio Farm Project completion
- Execution risk in asset sales and strategic alternativesImpact: HighLikelihood: High
The company’s remaining value depends on successfully monetizing the Ohio Farm Site or securing a partner/investor on acceptable terms.
Exposure: Residual asset value and future business model
Accounting
Judgemental itemsSold farms and IP are removed from continuing operations, changing revenue and expense comparability across periods.
Impact: Makes trend analysis harder because the remaining business is much smaller than prior periods.
The Ohio project and related equipment must be tested for recoverability when construction is paused or economics worsen.
Impact: Can create large non-cash charges that materially reduce reported earnings.
Management explicitly states additional funding is required and that there is substantial doubt about continuing operations.
Impact: Affects investor assessment of solvency, valuation, and financial statement presentation.
Disposals of farms, equipment, and IP require gain/loss recognition and careful classification.
Impact: Can create volatile one-time results that do not reflect ongoing operating performance.
Similar listed companies
Publicly listed companies with a comparable business focus.
Aibotics, Inc.
AIBT · Medicinal Chemicals & Botanical Products
Avidity Biosciences, Inc.
Pharmaceutical Preparations
Avidity Biosciences is a clinical-stage biopharmaceutical company built around its proprietary Antibody Oligonucleotide Conjugate, or AOC, platform.
Trans American Aquaculture, Inc
GRPS · Agricultural Prod-Livestock & Animal Specialties
OmniAb, Inc.
OABIW · Services-Commercial Physical & Biological Research
Abpro Holdings, Inc.
ABPWW · Biological Products, (No Diagnostic Substances)
Vital Farms, Inc.
VITL · Food and Kindred Products
Vital Farms is a U.S.
Last updated: 24/09/2026